{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -0.04, "sharesOutstanding": 32419000, "fiftyDayAverage": 0.25077, "fiftyDayAverageChange": -0.0007700026, "fiftyDayAverageChangePercent": -0.003070553, "twoHundredDayAverage": 0.221175, "twoHundredDayAverageChange": 0.028825, "twoHundredDayAverageChangePercent": 0.13032666, "marketCap": 10380175, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Alzinova AB", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "currency": "EUR", "financialCurrency": "SEK", "regularMarketOpen": 0.2455, "averageDailyVolume3Month": 316, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.1894, "fiftyTwoWeekLowChangePercent": 3.1254125, "fiftyTwoWeekRange": "0.0606 - 0.406", "fiftyTwoWeekHighChange": -0.15599999, "fiftyTwoWeekHighChangePercent": -0.38423643, "fiftyTwoWeekLow": 0.0606, "fiftyTwoWeekHigh": 0.406, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1607929200000, "priceHint": 4, "marketState": "REGULAR", "regularMarketChange": 0.0, "regularMarketTime": 1683892037, "regularMarketDayHigh": 0.252, "regularMarketDayRange": "0.2455 - 0.252", "regularMarketDayLow": 0.2455, "regularMarketVolume": 700, "regularMarketPreviousClose": 0.25, "bid": 0.237, "ask": 0.2975, "fullExchangeName": "Frankfurt", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.25, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "FRA", "shortName": "ALZINOVA AB", "longName": "Alzinova AB (publ)", "messageBoardId": "finmb_183463691", "market": "dr_market", "symbol": "78D.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Pepparedsleden 1", "city": "M\u00f6lndal", "zip": "431 83", "country": "Sweden", "phone": "46 7 08 46 79 75", "website": "https://www.alzinova.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Alzinova AB (publ), a biopharma company, engages in the development of an active immunotherapy for the treatment of Alzheimer's disease in Sweden. Its lead candidate is ALZ-101, an oligomer-specific vaccine for the treatment of Alzheimer's disease; and ALZ-201, a monoclonal antibody that is used for the treatment of toxic A\u00df oligomers. The company was founded in 2011 and is based in M\u00f6lndal, Sweden.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Kristina  Torfgard", "title": "Chief Exec. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hakan  Skogstrom", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anders  Sandberg Ph.D.", "age": 50, "title": "Chief Scientific Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anders  Bylock", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}